Delivery Order SPE2DR25D2003-SPE2DR26FR10Q
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Atomoxetine HCL 25 mg capsules in 30-count quantities, with a contract ceiling value of $2,955.73 and an ultimate completion date of December 9, 2025. This non-set-aside delivery order represents a competitively awarded purchase executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.53 to AmerisourceBergen Drug Corp for Atomoxetine HCL 80 mg capsules (30-count) on December 17, 2025, with completion due by December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded competitively. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.65 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 40 mg capsules (30-count units) on January 13, 2026, with completion targeted for January 14, 2026. The award was made on a non-competitive, firm fixed-price basis and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30 units, with a contract ceiling value of $2,326.72. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on a non-set-aside, competitive basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,281,057 units of Atomoxetine HCl 60 mg capsules. The delivery order is a firm-fixed price contract with a ceiling value of $1,022.40 and a period of performance through October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,096.92. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,012.36. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 40 mg capsules (30-count) valued at $1,036.01, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR10QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,422.91 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Atomoxetine HCL 25 mg capsules (30-count units). The contract, which is not set-aside and was competitively awarded, carries a firm fixed-price structure with an ultimate completion date of January 16, 2026. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under the company's larger pharmaceutical supply agreement with DLA. This award falls under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supplier to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999,999,999.00 IDC with DLA through December 2031, positioning the organization as a critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/14/26 |